✦ LIBER ✦

Risk-benefit profiles of antiarrhythmic therapy

✍ Scribed by Ronald W.F. Campbell; Kishore Nimkhedkar

Book ID: 113116417
Publisher: Elsevier Science
Year: 1989
Tongue: English
Weight: 417 KB
Volume: 64
Category: Article
ISSN: 0002-9149
DOI: 10.1016/0002-9149(89)91199-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Benefit-Risk Assessment of Current Antia

Benefit-Risk Assessment of Current Antiarrhythmic Drug Therapy of Atrial Fibrillation

✍ Stefan H. Hohnloser 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 242 KB

Risk and Benefit Class III Antiarrhythmi

Risk and Benefit Class III Antiarrhythmic Drugs

📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 189 KB

A Benefit-Risk Assessment of Class III A

A Benefit-Risk Assessment of Class III Antiarrhythmic Agents

✍ Dr Bente Brendorp, Ole Dyg Pedersen, Christian Torp-Pedersen, Naji Sahebzadah, L 📂 Article 📅 2002 🏛 Springer International Publishing AG 🌐 English ⚖ 235 KB

Risk–benefit effects of tocolytic therap

Risk–benefit effects of tocolytic therapy

✍ Pryde, Peter G; Janeczek, Susan; Mittendorf, Robert 📂 Article 📅 2004 🏛 Informa plc 🌐 English ⚖ 209 KB

Combining Antiarrhythmic Drugs and Impla

Combining Antiarrhythmic Drugs and Implantable Devices Therapy: Benefits and Outcome

✍ Massimo Santini; Claudio Pandozi; Renato Ricci 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 64 KB

Antiarrhythmic drugs for the maintenance

Antiarrhythmic drugs for the maintenance of sinus rhythm: Risks and benefits

✍ John Camm 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 414 KB